In the preclinical model of Metabolic Syndrome, due to the genetic ablation of the LDL receptor (ldlr-/-), combined with the Western Diet, NTCI controlled the metabolic hypersensitivity to a sublethal dose of LPS, a well-known inducer of microbial inflammation17. This evidence concerns the gene LDLR and metabolic syndrome.